Short answer: The best places to buy TB-500 in 2026 are research suppliers that sell only to laboratory buyers, publish a lot-specific certificate of analysis (COA) from a named third-party lab, and keep their research-use-only (RUO) language identical on the label, product page, and paperwork. TB-500 is not an FDA-approved drug. It is a synthetic peptide supplied strictly for in vitro and laboratory research, and nothing in this guide is guidance for use in humans or animals.
This guide is written for procurement and analytical staff sourcing TB-500 for cell-based assays, analytical method development, and reference-standard work. It covers what changed legally in 2026, how to judge a vendor on evidence you can check yourself, and the red flags that should end a vendor conversation. If you are new to research peptides, start with our Research Library overview first.
Looking for a documented source? Our TB-500 (Thymosin B4 Acetate) 10mg is listed for laboratory research only, and the checklist below is the same standard we hold our own listings to.
Key takeaways
- TB-500 has no FDA approval for any use. It is sold in the U.S. only as a research chemical.
- In April 2026, FDA removed TB-500 from its Category 2 compounding list, and in July 2026 an FDA advisory committee voted 8-6 to recommend adding it to the 503A bulks list. That vote did not approve TB-500 or make it legal to sell for human use.
- A “research use only” disclaimer is not a legal shield. FDA warning letters in 2026 targeted peptide sellers whose marketing implied human use despite the label.
- Judge a vendor on three separate test results (identity, purity, and net peptide content) from a named, preferably ISO/IEC 17025-accredited, laboratory.
- TB-500 and thymosin beta-4 derivatives are prohibited at all times under the WADA Prohibited List.
- The cleanest compliance signal a vendor gives is consistency: the same RUO wording everywhere, no dosing talk, no health claims.
TB-500 Legal Status in 2026: What Changed and What Did Not
TB-500 remains an unapproved substance in the United States: legal to supply for laboratory research, not legal to market or sell for human use. Three 2026 developments matter to buyers, and none of them changed that core fact.
What TB-500 is
TB-500 is a synthetic peptide modeled on the actin-binding region of thymosin beta-4 (Tβ4), a naturally occurring 43-amino-acid protein. FDA’s own evaluation memo for the July 2026 advisory meeting describes TB-500 free base as a seven-amino-acid synthetic fragment of thymosin beta-4. Published biochemistry identifies the LKKTETQ sequence (residues 17-23) as the central actin-binding domain of the parent protein (Sosne et al., FASEB Journal, 2010). Research on full-length Tβ4 does not automatically transfer to the fragment, a distinction independent reviewers stress (BSCG).
2026 regulatory timeline
| Date | Event | What it means for research buyers |
|---|---|---|
| Jul 23, 2026 | FDA’s Pharmacy Compounding Advisory Committee (PCAC) voted 8-6 (1 abstention) to recommend TB-500 free base and acetate for the 503A bulks list, evaluated for wound healing (McDermott Will & Schulte) | A recommendation only. FDA must still act through rulemaking before licensed pharmacies may compound it (Pharmacy Times) |
| Apr 22, 2026 | FDA removed TB-500 and 11 other peptides from Category 2 of its interim 503A list (FDA 503A categories list; Mondaq) | No longer flagged as “significant safety concerns” for compounding, but not placed on any approved list |
| Sep 29, 2023 | FDA placed TB-500 among peptides in Category 2 of the interim 503A list | The baseline most older articles still describe |
Bottom line: The PCAC process concerns licensed compounding pharmacies working from prescriptions. It does not cover research chemical vendors and does not authorize anyone to sell TB-500 for personal use. For the official process, see FDA’s page on bulk drug substances used in compounding under section 503A.
“Research use only” is not a legal loophole
FDA judges a product by its intended use, shown by the seller’s whole presentation, not by a disclaimer. In August 2026, FDA issued warning letters to five online peptide vendors that relied on RUO language while their marketing pointed to human use (Arent Fox Schiff; McDermott Will & Schulte). An earlier round published April 7, 2026 hit seven research-peptide websites on the same theory (Policy Canary).
For buyers, the lesson is practical. A vendor that pairs an RUO label with dosing charts, “recovery” language, injection supplies, or customer testimonials is building a legal record against itself, and your supply chain with it.
Sport and testing programs
Thymosin-β4 and its derivatives, with TB-500 named as an example, appear in section S2 of the WADA Prohibited List (Drugs.com WADA S2 reference). The 2026 List took effect January 1, 2026 (FIBA). Independent certifier BSCG notes TB-500 is prohibited at all times for WADA-tested athletes and flags added risk for military testing programs (BSCG).
Outside the United States
Rules vary by country, and some regulators schedule peptides of this class as prescription-only medicines. Confirm local rules with your institution’s compliance office before ordering across borders. We are not lawyers, and this section is general information, not legal advice.
How to Choose a Reputable TB-500 Research Peptide Vendor
The best TB-500 vendor is the one whose claims you can verify before you pay. A purity percentage on a product page is a summary of a test you have not seen; the documents behind it are what you are actually buying. This guide is based on publicly available supplier documentation and regulatory records, not on first-hand purchases from every vendor.
The five checks that separate documented vendors from the rest
- Lot-specific COA. The lot number on the certificate must match the lot number on the vial you receive. A generic “representative” COA describes a different batch.
- Named testing laboratory. A named lab can be looked up and contacted. Anonymous “in-house” or “third-party tested” claims cannot be checked.
- Accredited methods. Ask whether the lab holds ISO/IEC 17025 accreditation and whether the peptide methods sit inside its accredited scope. The standard covers the competence, impartiality, and consistent operation of testing labs (ANAB), and labs are accredited by a national body rather than self-certified (CASRAI).
- Three separate results. Identity, purity, and net peptide content should each appear as their own figure (table below).
- Consistent RUO framing. The same research-only wording on the label, product page, COA, checkout, and emails, with no dosing or health language anywhere.
What the three core analyses measure
| Analysis | What it measures | What it catches |
|---|---|---|
| RP-HPLC | Share of detected peptide material that is the target sequence | Synthesis impurities, deletion sequences, poor purification |
| Mass spectrometry (MS) | Observed molecular weight vs. the theoretical weight of the sequence | Wrong molecule, truncation, unexpected modification |
| Net peptide content | Peptide mass as a share of total vial mass | Excess water, counterions (TFA or acetate), and salts |
These results are not interchangeable. Two vials can share an identical HPLC purity yet hold different amounts of actual peptide, which matters in any concentration-response assay. MS supports identity but cannot tell apart species of the same nominal mass; MS/MS fragmentation settles that when a study depends on it. For a walkthrough of each field, see our guide on [how to read a peptide certificate of analysis] [link].
Red flags that should end the conversation
- Dosing charts, “protocols,” reconstitution or injection guides, or bundled bacteriostatic water and syringes
- Words like healing, recovery, injury, performance, or anti-aging anywhere on the site, including reviews
- Customer testimonials describing personal results
- A COA with no lab name, no lot number, or a lot number that does not match the vial
- Only a purity figure, with no chromatogram, MS result, or net peptide content
- No age gate, no buyer attestation of research use, or willingness to ship to individuals who state personal use
- Prices far below the market with no documentation to explain how
Questions to send a vendor before ordering
A specific request gets a specific answer, and gaps become obvious. Copy this list into your inquiry:
- The COA for the exact lot you will ship, with lot number
- MS identity result showing observed and theoretical molecular weights
- RP-HPLC purity with the chromatogram
- Net peptide content as a separate figure
- The testing lab’s name, and whether its methods are inside an ISO/IEC 17025 accredited scope
- Storage conditions maintained before shipping
A vendor with real lot records answers this in one reply. Slow, partial, or evasive answers are themselves data.
What to record when the material arrives
Log the lot number, COA, receipt date, packaging condition, and storage location. Note the appearance of the lyophilized cake on opening; a collapsed or glassy cake can signal moisture or heat exposure in transit. Record when a study switches lots, since lot-to-lot variation is a routine first suspect when results shift. Over several orders, this log becomes your own evidence of vendor consistency. See our TB-500 (Thymosin B4 Acetate) 10mg research listing for how we present lot documentation, and our BPC-157 10mg research listing for a related compound.
Where to buy TB-500 for research: the short list of vendor types
| Vendor type | Fit for research buyers | Watch for |
|---|---|---|
| Established catalog chemical suppliers | Strongest documentation, institutional ordering, sell to labs only | Higher prices, may require an institutional account |
| Custom peptide synthesis companies | Made to your spec with full analytical package | Lead times and minimum quantities |
| Specialist research peptide retailers | Faster, smaller quantities | Quality varies widely; apply all five checks above |
| Marketplaces, social media, forum sellers | Not appropriate | No traceability, frequent human-use marketing |
Frequently Asked Questions
Is TB-500 FDA approved?
No. TB-500 is not approved by the FDA for any use. It is supplied in the U.S. only as a research chemical for laboratory work.
Did the July 2026 FDA vote make TB-500 legal?
No. The PCAC voted 8-6 to recommend TB-500 for the 503A bulks list, which governs licensed compounding pharmacies. FDA has not finalized that change, and the vote did not approve TB-500 as a drug or permit its sale for personal use.
Is it legal to buy TB-500 for research?
Purchasing an unapproved peptide for genuine in vitro or laboratory research is generally lawful in the U.S. when the seller and buyer both keep the transaction within research use. Selling or buying it for human consumption is not. Check your state, institution, and country rules.
Does a “research use only” label protect a vendor?
Not on its own. FDA looks at the seller’s full marketing to decide intended use, and its 2026 warning letters rejected RUO disclaimers when the surrounding content pointed to human use.
What should a TB-500 COA include?
A lot number matching your vial, the testing lab’s name, an MS identity result with observed and theoretical molecular weights, an RP-HPLC purity result with chromatogram, and net peptide content as a separate figure.
Is TB-500 banned in sports?
Yes. Thymosin-β4 and its derivatives, including TB-500, are prohibited at all times under section S2 of the WADA Prohibited List.
Research Use Only Disclaimer
TB-500 is not approved by the U.S. Food and Drug Administration for any use. All products and information referenced on Peptides Exchange are intended solely for in vitro laboratory research by qualified professionals. They are not for human or veterinary use, not for consumption, and not intended to diagnose, treat, cure, or prevent any disease. Nothing in this article is medical or legal advice. Buyers must be 21 or older and are responsible for complying with all applicable federal, state, and local laws. See our full [Research Use Only policy] [link].
Related Articles
- Research Library: all articles
- TB-500 (Thymosin B4 Acetate) 10mg: research listing and lot documentation
- [How to Read a Peptide Certificate of Analysis] [link]
- [BPC-157: Research Overview and 2026 Regulatory Status] [link]
- [Gonadorelin Acetate Research Profile] [link]
- [Snap-8 (Acetyl Octapeptide-3) Research Profile] [link]
- [NAD+ Research Overview] [link]
Sources
- U.S. FDA. Bulk Drug Substances Nominated for Use in Compounding Under Section 503A (categories list, updated Apr 22, 2026)
- U.S. FDA. Evaluation of TB-500-Related Bulk Drug Substances for Inclusion on the 503A Bulks List (PCAC briefing, May 2026)
- U.S. FDA. PCAC Meeting Questions, July 23-24, 2026
- U.S. FDA. Bulk Drug Substances Used in Compounding Under Section 503A of the FD&C Act
- McDermott Will & Schulte. Bulk List Bound: PCAC Backs Majority of Peptides in Two-Day Public Meeting
- Pharmacy Times. What the Peptide Vote Actually Changes at My Counter
- Mondaq. FDA Signals Potentially Evolving Stance Toward Compounding of Certain Peptides
- Arent Fox Schiff. RUO-ined: Five Peptide Vendors Learn That “Research Use Only” Is Not a Legal Strategy
- McDermott Will & Schulte. Client alert on FDA warning letters to online peptide sellers
- Policy Canary. FDA Hits Seven Peptide Websites in a Single Day (April 2026)
- Drugs.com. WADA S2: Peptide Hormones, Growth Factors, Related Substances and Mimetics
- FIBA. WADA List of Prohibited Substances and Methods in Effect for 2026
- BSCG. TB-500: Status, Risks and Bans in Sport and Military
- BSCG. TB-500 Peptide: Benefits, Safety, Legal Status and Research
- Sosne G, Qiu P, Goldstein AL, Wheater M. Biological activities of thymosin β4 defined by active sites in short peptide sequences, FASEB J. 2010;24:2144-2151
- ANAB. ISO/IEC 17025 Testing Laboratory Accreditation
- CASRAI. ISO/IEC 17025 explainer
- Bluum Peptides. Best Places to Buy TB-500 in 2026 (reference article)
Leave a Reply